- Home
- PRVA
as 05-30-2025 4:00pm EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.8B | IPO Year: | 2021 |
| Target Price: | $27.93 | AVG Volume (30 days): | 770.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.12 | EPS Growth: | -20.04 |
| 52 Week Low/High: | $16.37 - $26.09 | Next Earning Date: | 05-08-2025 |
| Revenue: | $1,801,244,000 | Revenue Growth: | 6.79% |
| Revenue Growth (this year): | 90.57% | Revenue Growth (next year): | 10.43% |
Stock Insider Trading Activity of Privia Health Group Inc. (PRVA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mehrotra Parth | PRVA | Chief Executive Officer | May 12 '25 | Sell | $24.76 | 29,682 | $734,275.95 | 407,234 | |
| Mountcastle David | PRVA | EVP & Chief Financial Officer | Apr 30 '25 | Sell | $23.33 | 3,445 | $80,371.85 | 176,231 | |
| Mehrotra Parth | PRVA | Chief Executive Officer | Apr 30 '25 | Sell | $23.21 | 32,465 | $753,067.20 | 407,234 | |
| Morris Matthew Shawn | PRVA | Director | Apr 30 '25 | Sell | $23.33 | 10,309 | $240,508.97 | 59,792 | |
| Mountcastle David | PRVA | EVP & Chief Financial Officer | Apr 2 '25 | Sell | $22.38 | 5,630 | $125,999.40 | 176,231 | |
| Mehrotra Parth | PRVA | Chief Executive Officer | Mar 12 '25 | Sell | $24.03 | 10,514 | $252,651.42 | 407,234 | |
| Mountcastle David | PRVA | EVP & Chief Financial Officer | Mar 10 '25 | Sell | $24.21 | 5,851 | $141,658.23 | 176,231 | |
| Mehrotra Parth | PRVA | Chief Executive Officer | Mar 10 '25 | Sell | $24.21 | 18,934 | $458,409.92 | 407,234 | |
| Fargis Edward C | PRVA | EVP & General Counsel | Mar 10 '25 | Sell | $24.21 | 4,967 | $120,255.81 | 95,492 |
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance
Argus Research
11 days ago
PRVA: What does Argus have to say about PRVA?
StockStory
12 days ago
3 Healthcare Stocks with Mounting Challenges
Simply Wall St.
17 days ago
Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings
StockStory
17 days ago
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks
StockStory
18 days ago
Healthcare Technology for Providers Stocks Q1 Earnings Review: Premier (NASDAQ:PINC) Shines
Argus Research
18 days ago
PRVA: Raising target price to $27.00
StockStory
20 days ago
3 Dawdling Stocks with Mounting Challenges
Compare PRVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.